Late Breaking Abstract - Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof of concept clinical trial Source: Virtual Congress 2021 – Highlights in COVID-19 diagnosis and treatment Year: 2021
Efficacy and costs of telehealth for the management of COPD: PROMETE II, a multicentre, randomized controlled trial Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care Year: 2017
Chinese herbs in treatment of postinfectious cough: A multi-centre, randomized, double-blind, placebo-controlled trial Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013
A trial like ALIC4 E: why design a platform, response-adaptive, open, randomised controlled trial of antivirals for influenza-like illness? Source: ERJ Open Res, 4 (2) 00046-2018; 10.1183/23120541.00046-2018 Year: 2018
Efficacy and safety of sequential three-step empirical therapy for chronic cough: a multi-center clinical study Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017
Clinical effectiveness of self-management of asthma in general practice: a randomized controlled trial Source: Eur Respir J 2001; 18: Suppl. 33, 518s Year: 2001
Late Breaking Abstract - A randomised, double-blind, placebo controlled, clinical trial evaluating imatinib in patients with severe COVID-19 Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19 Year: 2021
Late Breaking Abstract - Efficacy and safety of eliapixant in refractory chronic cough: Results of the PAGANINI 12-week, randomized, placebo-controlled Phase 2b study Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021
Cost-effectiveness of self-management in asthmatics: a 1-yr follow-up randomized, controlled trial Source: Eur Respir J 2001; 17: 206-213 Year: 2001
A randomized, controlled, open-label study to evaluate the efficacy and safety of oral lopinavir-ritonavir in adults hospitalized with COVID-19 virus infection Source: Virtual Congress 2020 – Chinese programme 2020: Part I Year: 2020
Effectiveness of influenza vaccination in asthmatic children: randomised, double-blind, placebo-controlled trial Source: Eur Respir J 2002; 20: Suppl. 38, 146s Year: 2002
Evaluation of biological quality control variance in a multi-center clinical trial for inhaled insulin Source: Annual Congress 2007 - Quality, sleep and physiology Year: 2007
Efficacy and safety of new drugs for M/XDR-TB: what have we learned from observational studies? Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis Year: 2019
Abediterol in stable asthma:efficacy, safety and tolerability results from a Phase II, randomised, crossover study Source: International Congress 2014 – Asthma and COPD management Year: 2014
Real world effects of COPD medications: a cohort study with validation against results from randomised controlled trials Source: Eur Respir J, 57 (3) 2001586; 10.1183/13993003.01586-2020 Year: 2021
Evaluation of data requirements to establish biologic quality control ranges in a multi-center clinical trial for inhaled insulin Source: Annual Congress 2008 - New challenges and maintained quality: lung function for the future Year: 2008
Long-term safety of pirfenidone: results of the prospective, observational PASSPORT study Source: ERJ Open Res, 4 (4) 00084-2018; 10.1183/23120541.00084-2018 Year: 2018
Late Breaking Abstract - Long-term safety of pirfenidone in a real-world setting: final results from the prospective, observational PASSPORT registry Source: International Congress 2017 – Late-breaking findings in pulmonary diseases Year: 2017
Evaluation of the tolerability of the dornase alfa based on the results of a multicenter scientific program of post-marketing use of the medicine Source: Virtual Congress 2021 – Cystic fibrosis Year: 2021